Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 for Recurrence Prevention in NMIBC
NCT04664816Unknown
- Sponsor
- Mansoura University
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial of omega-3-acid triglycerides in non-muscle-invasive bladder cancer (NMIBC), sponsored by Mansoura University. Primary endpoint: Time to first recurrence at 2 years. Status: unknown.
02
Drugs
omega-3-acid triglycerides
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT04664816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04664816.